These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3752754)

  • 21. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation.
    Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV
    Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory ventricular tachycardia with flecainide.
    Wynn J; Fingerhood M; Keefe D; Maza S; Miura D; Somberg JC
    Am Heart J; 1986 Jul; 112(1):174-5. PubMed ID: 3728275
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of flecainide in the treatment of ventricular arrhythmia].
    Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
    Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of sustained ventricular tachycardia inducibility in patients with nonsustained ventricular tachycardia and chronic coronary artery disease.
    Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
    Am Heart J; 1989 May; 117(5):1050-9. PubMed ID: 2711964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
    Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
    JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of atrial tachycardias with flecainide acetate.
    Creamer JE; Nathan AW; Camm AJ
    Br Heart J; 1985 Feb; 53(2):164-6. PubMed ID: 3966957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of flecainide in patients with non-sustained ventricular tachycardia and impaired left ventricular function].
    De Marzio P; Morelli S; Suppa M; Caputo V; Mango L; Guido V; Cardoni F; Gnecchi M; Aguglia F
    Minerva Cardioangiol; 1991; 39(1-2):35-9. PubMed ID: 1906997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H
    Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
    Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.